RIVENDELL GROUP LLP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the 340B Drug Discount Program; drug pricing; and general education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to diversity in clinical trials. Funding for flu preparedness and the SNS. Issues relating to privacy and securing medical research data and personal health information of patients/consumers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Medicare/Medicaid MMM
Issues related to the 340B Drug Discount Program; drug pricing; and general education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to diversity in clinical trials. Funding for flu preparedness and the SNS.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.